Physician profile
Katie Sanderson
NPI 1700256351
$5,082.96
in general payments reported to CMS, 2019-2025
41 companies · $934 in 2025
The $934 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,109 · 2022: $1,180 · 2023: $1,115 · 2024: $745 · 2025: $934.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,640 · Education: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,639.81 |
| Education | $153.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $695.10 | 2021-2024 | |
| Radius Health, INC. | $613.24 | 2021-2025 | Tymlos |
| Astellas Pharma US INC | $494.60 | 2021-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $446.37 | 2023-2025 | Gemtesa, Myfembree |
| Mayne Pharma Commercial LLC | $353.84 | 2021-2025 | |
| Pfizer INC. | $274.59 | 2021-2024 | |
| Hologic Sales and Service, LLC | $240.02 | 2021-2025 | Aptima |
| Millicent US INC | $210.57 | 2023-2025 | Intrarosa, Femring, Femlyv |
| Aspira Women'S Health INC | $169.02 | 2021-2022 | |
| Exeltis, USA INC. | $126.49 | 2021-2023 | Slynd |
| Intuitive Surgical, INC. | $125.55 | 2022 | |
| Myovant Sciences INC. | $122.27 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $115.52 | 2021-2025 | |
| Therapeuticsmd, INC. | $109.87 | 2021-2022 | |
| Organon LLC | $82.71 | 2022-2025 | Nexplanon |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Sanderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.